Milestone Scientific Shareholders Approve Stock & Equity Plan Increases
Milestone Scientific Inc. held its 2026 Annual Meeting, where shareholders elected five incumbent directors, approved an increase in authorized common stock from 125 million to 135 million shares, and increased the shares available for its equity incentive plan from 11.5 million to 28.75 million. Shareholders also approved executive compensation and ratified Grassi & Co. as auditors. Separately, the Board re-elected Kelly Ulto and Greg Shilling as directors and appointed them to various committees.
Key Highlights
- Five incumbent directors elected by shareholders at the 2026 Annual Meeting.
- Authorized common stock increased from 125,000,000 to 135,000,000 shares (96.59% approval).
- Equity incentive plan shares increased from 11,500,000 to 28,750,000 (80.82% approval).
- Executive officer compensation approved on a non-binding advisory basis.
- Grassi & Co. ratified as independent auditors for fiscal year 2026.
- Kelly Ulto and Greg Shilling re-elected as directors by the Board.
- Ms. Ulto appointed Chair of the Audit Committee.
- Mr. Shilling appointed Chair of the Compensation Committee.
Price Impact
More from MLSS
Milestone Scientific Directors Convert $466K in Notes to Common Stock
Milestone Scientific Q2 Revenue $2.8M, Medical Segment +300%
Milestone Scientific Appoints Two New Directors; Chair Becomes Executive Chair